Pandemic influenza vaccine
Ended Awarded
- Contract number
- HHSO1000002
- Awardee
-
Glaxosmithkline Holdings (Americas) Inc. UEI QQH9KHXNCG81
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $97,200,000
Award facts
- Opportunity
-
- DHHSORDCVB0608 Solicitation number
- Contract value 8% obligated
-
- $198,000,000.00 Current, with exercised options
- $1,200,000,000.00 Potential, with all options
- Completion date 100% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Non-Competitive Delivery Order · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19102, USA
- Legislative mandates
-
- Walsh-Healey Public Contracts Act FAR subpart 22.6
Award details come from SAM.gov/FPDS.
Quick answers
Who was awarded contract HHSO1000002?
HHSO1000002 was awarded to Glaxosmithkline Holdings (Americas) Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on July 27, 2007.
How much is contract HHSO1000002 worth?
The government has obligated $97,200,000 on HHSO1000002. Its current value, with exercised options, is $198,000,000. Its potential value, with all options, is $1,200,000,000.
Is contract HHSO1000002 an order under another contract?
Yes. HHSO1000002 is a delivery order under HHSO100200700027I, an indefinite delivery contract.
Was contract HHSO1000002 competed?
The extent of competition for HHSO1000002 was non-competitive delivery order. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award